Info

Fujirebio Diagnostics, Inc. is a world leader in the production of in vitro diagnostics, and biomarkers. The name Fujirebio (pronounced Fuji-Ray-Bee-Oh) symbolizes restoration of health. Our parent company, Fujirebio, Inc., a leading healthcare company in Japan with a focus on diagnostics, acquired Fujirebio Diagnostics in 1988. In June 2006, CanAg Diagnostics of Sweden, now called Fujirebio Diagnostics AB, joined Fujirebio Diagnostics to strengthen the company's product offerings, distribution network, and research and development capabilities. Fujirebio Diagnostics specializes in the manufacturing of manual assay products distributed throughout the U.S. and around the world, as well as custom-developed products for use through our worldwide network of distribution partners. With close to 50,000 square feet of manufacturing space between our U.S. headquarters in Malvern, PA, and in Sweden, Fujirebio Diagnostics' proven manufacturing process has made us a global partner of choice among leading diagnostic companies. Looking forward, we will remain committed in our efforts to deliver quality and value with products that have made us the standard of excellence in the industry and we will continue to utilize our resources to develop new, innovative assays that aid healthcare professionals in the treatment of human disease.